RELIGARE Religare Enterprises Q4 FY26 results (Jan–Mar 2026) and concall
Religare Enterprises reported a year of strategic rebuilding in FY26, marked by a 14.7% increase in consolidated total income and the approval of a demerger scheme to create two focused entities. Care Health Insurance delivered strong growth and improved profitability, while Religare Finvest achieved positive PAT. However, Religare Broking saw a decline in full-year performance, and Religare Housing Finance remained loss-making, though with improving trends.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 110.0%, net profit down 36.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 23 | 10 | 10 | 9 | 6 −74% | 23 +130% | 21 +110% |
| EBITDA | 76 | -61 | 237 | 15 | 67 −12% | -95 −56% | 143 −40% |
| Net profit | 69 | -63 | 151 | 8 | 46 −33% | -77 −22% | 96 −36% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
